Directors & Officers
| Name | Title | Year Born |
|---|---|---|
| Mr. Heru Firdausi Syarif | President Director | 1966 |
| Mr. Hendry Herman | Sales Director & Director | 1982 |
IRRA
Itama Ranoraya
ISIN
ID1000151707
Employees
232
Phone
62 21 2906 7207
Fiscal year end
December
Address
MT. Haryono Square Lt. 1, Jakarta Timur, Indonesia, 13330
348.00
-8.00 (-2.25%)
IDR · JK
52-week range
322.00
615.00
Trading at 9% of the 52-week range
Market Cap
509.64B
P/E Ratio
8.04
Forward P/E
0.00
Book Value
400.90
Div. Yield
N/A
% Institutions
0.00%
% Insiders
80.01%
1 Year
-23.3%3 Year
-26.7%10 Year
-34.3%Description
PT Itama Ranoraya Tbk wholesale trades in laboratory and pharmaceutical equipment, and medical devices for humans in Indonesia. It offers in vitro diagnostics products comprising rapid test, serology, glucose diagnostic, NAPZA test, and clinical laboratory; medical imaging products, including bone densitometer, C-arm, flat panel digital detector, mobile and stationary x-ray, and mammography; nefrology, blood and transfusion, orthopedic, radiotherapy, and surgical products; and hospital supplies and hospital kitchen equipment. The company also provides cold chain management, such as cold room, bloodbank, and pharmaceutical refrigerator; critical care; and pharmaceutical supplements, as well as maternal and neonatal care products. In addition, it leases office space. It sells its products under the oneject, Abbott, Terumo, DIRUI, Medtronic, mindray, ZOLL, Sansin, Vestfrost, ASCENSIA, Hemocue, CUREXO, SATInc., PT. MEGA, Planmed, Sinmed, Balmed, KSM CARE, Trisan Care, Shamrock, OTORO, GEA, Hologic, IS, Avimac, RadmediX, and SMAM brand names. The company was founded in 1988 and is based in Jakarta Timur, Indonesia. PT Itama Ranoraya Tbk operates as a subsidiary of PT Global Dinamika Kencana.
Actions
Add an action for IRRA.JK, or sign in to see your action list.
People
Financial Highlights
Market Cap:
$509.64B
EBITDA:
$116.78B
P/E Ratio:
$8.04
Book Value:
$400.90
Earnings/Share:
$42.06
Profit Margin:
6.26%
Operating Margin:
8.94%
ROA (TTM):
2.63%
ROE (TTM):
11.47%
Revenue (TTM):
$1,048.18B
Revenue/Share (TTM):
$678.73
Earnings Growth (YOY):
-1.90%
Revenue Growth (YOY):
-15.70%
Valuation Metrics
Enterprise Value:
$1,571.16B
Trailing P/E:
8.04
Forward P/E:
0.00
Shares Statistics
Shares Outstanding:
1.51B
Shares Float:
247.12M
% Insiders:
80.01%
% Institutions:
0.00%
Stock Price History
1 Year Price History
3 Years Price History
10 Years Price History
Max Price History
Financial Charts
Revenue, Net Income & Operating Cash Flow (Yearly)
Change % vs Prior Year
Revenue, Net Income & Operating Cash Flow (Quarterly)
Change % vs Prior Quarter
Operating Expenses (Yearly)
Operating Expenses (Quarterly)
Balance Sheet (Yearly)
Balance Sheet (Quarterly)
Assets Breakdown (Yearly)
Assets Breakdown (Quarterly)
Liabilities Breakdown (Yearly)
Liabilities Breakdown (Quarterly)
Income Statement Waterfall
Line Item
Step Type
Value
Revenue
adjust
$1,100.21B
Cost of Goods Sold
adjust
$-856.15B
Gross Profit
subtotal
$244.06B
SG&A
adjust
$-25.40B
Other Operating Expense
adjust
$-117.99B
Operating Income
subtotal
$100.68B
Other / Non-Operating Items
adjust
$-35.15B
Net Income
subtotal
$65.53B
Earnings Per Share (EPS) History
Financial Ratios
📦 Raw API Data (JSON Explorer)
Comprehensive raw data returned from the EOD Fundamentals API. Expand sections below to drill down.